Biotech Company, CEO Named In SEC Suit Over Alleged COVID-19 Blood Test Device

(December 21, 2020, 9:49 AM EST) -- NEW YORK — The Securities and Exchange Commission sued a biotechnology company and its CEO in New York federal court on Dec. 17, alleging that the defendants violated federal securities laws...
To view the full article, register now.